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ABSTRACT
Genetic screens are performed in order to characterize genes and mutations, often
relating to developmental processes. A previous genetic screen performed in Drosophila
melanogaster found three mutations on the second chromosome affecting glial cell
development: FF12, DD68, and D19. These mutations each disrupted the pattern and
expression of reversed polarity (repo), a target gene of the glial fate master regulator,
glial cells missing (gcm). Here, I use recombination mapping with phenotypically
observable dominant markers to locate the genetic map position of each mutation. This
method provides a rapid estimate of the mutations’ locations that can then be tested
against molecularly-defined deficiencies to pin-point a precise position. FF12, DD68, and
D19 were all determined to be on chromosome arm 2R.
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CHAPTER 1
BACKGROUND AND INTRODUCTION
1.1: Genetic Screens in Drosophila
Genetic screens are used to select for individuals that possess a specific phenotype
in a mutagenized population (St. Johnston, 2002). The phenotype observed from a
mutation can provide insight into the function of a gene. Performing genetic screens in
Drosophila has proven to be useful because of the many developmental processes that
have been conserved between flies and vertebrates (St. Johnston, 2002). Famously,
Hedgehog and the vertebrate homolog Sonic Hedgehog have similar functions in limb
patterning. Additionally, 197 of 287 human disease genes contain a homolog in
Drosophila (St. Johnston, 2002). The ability to easily perform genetic screens in
Drosophila can, therefore, be analyzed not only to understand each gene’s role within the
fly but also its vertebrate counterpart (St. Johnston, 2002).
In order to carry out genetic screens, scientists had to create a way to generate
mutations. In 1968, Lewis and Bacher described the use of ethyl methane sulphonate
(EMS) to induce mutations in Drosophila (Lewis and Bacher, 1968). Still, the most
commonly used mutagen in Drosophila, EMS, an alkylating agent, is fed to flies to
induce a high occurrence of point mutations in their DNA. Point mutations can result in
missense or nonsense mutations causing a disruption in gene function (St. Johnston,
2002). Therefore, the prevalence of mutations in a gene is dependent on the size of the
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gene’s coding regions and the number of critical aminio acids that it contains (Greenspan,
2004).
Traditional genetic screens have been used to identify mutations that affect
embryo patterning. Winning a Nobel prize for their work, Christiane Nüsslein-Volhard
and Eric Wieschaus performed a mutagenesis screen finding most of the mutations in
genes which are essential to patterning in Drosophila’s development (Nüsslein-Volhard
and Wieschaus, 1980). The model organism has key features that allowed for success
when Nüsslein-Volhard and Wieschaus searched for these developmental mutations.
One, Drosophila has an exoskeleton which allows the patterning of the embryo to be
visualized. Two, few mutations prevent embryonic development at early stages because
the mother passes maternal mRNA to the egg eliminating the need for the embryo’s
genes to be transcribed for patterning (St Johnston, 2002).
Although major accomplishments have been achieved with traditional screens,
they do have disadvantages. One limitation of traditional genetic screens is they are only
capable of identifying a mutation’s earliest phenotype. This limitation is applicable to
several vital proteins passed maternally to the embryo (e.g. Wingless) (St Johnston,
2002). The zygotic phenotype of these genes in homozygous mutants is only visible when
the maternal protein supply dissipates. Since this is a gradual process, later functions or
phenotypes of the target gene cannot be analyzed. New screens have been developed to
bypass this issue such as enhancer and suppressor screens and clonal screens (St
Johnston, 2002).
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1.2: Mapping Mutations
A key feature of Drosophila is their polytene chromosomes. Polytene
chromosomes are formed from non-disjunction occurring in individual chromosomes that
have sustained multiple rounds of replication (Zhimulev et. al., 2016). They have clear,
distinctive banding patterns, making it possible to correlate genetic map positions
(expressed in centiMorgans) with physical features of the chromosomes (Greenspan,
2004). This has allowed DNA sequences to be mapped to specific physical locations on
the chromosome (expressed by numbered segments). Banding pattern is a ubiquitous
organization convention, common to both polytene and normal, non-polytene,
chromosomes. The universality provided by these chromosomes warrants them as the
prototype for eukaryotic interphase chromosomes and makes them beneficial for mapping
(Zhimulev et. al., 2016).
Knockout mutations are essential in understanding the cellular function of genes
(Kahsai and Cook, 2018). In addition, different mutations such as those that affect levels
of gene expression or protein activity can provide insight that knockout mutations cannot.
Many mutations present in Drosophila have been characterized phenotypically, but these
mutations have not been identified with sequence-defined genes. These stocks are
possibly beneficial but rarely sought after by geneticists. Typically, geneticists
researching specific sequence-defined genes or processes focus on mutations that are
associated with that specific gene, not considering the unmapped mutations as possible
alleles. Therefore, mapping mutations can lead to new, more holistic understandings of
related genes’ functions (Kahsai and Cook, 2018).
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Simple techniques creating chromosomal deletions with breakpoints known at the
single nucleotide level are being used to map mutations to very precise positions on the
chromosome (Kahsai and Cook, 2018). Drosophila now has nearly complete genomic
deletion coverage (>98%) and subdivisions between breakpoints, more than any other
multicellular organism (Cook et. al., 2012). While blindly using deletion
complementation as a mapping method can be slow and labor intensive, homologous
chromosome recombination can be taken advantage of to advance the mapping process
(Sapiro et. al., 2013). Recombination analysis is a reliable mapping method that has been
used for over 100 years. In order to obtain a location from recombination methods, the
frequency of chromosomal exchange is compared to a reference locus. The resolution of
recombination mapping is positively correlated with the density of markers within the
stock and the number of recombinant progeny examined. Many methods are used to
achieve a high density of markers such as single-nucleotide polymorphisms, molecularly
defined P-elements, and recessive markers. While all effective, these methods of
recombination mapping are all labor intensive (Sapiro et. al., 2013).
One method of recombination mapping that provides less labor-intensive and
more rapid results is the use of pairs of dominant, phenotypically visible markers. This
method reduces the number of crosses and generations necessary to estimate genetic map
positions (Sapiro et. al., 2013). Since easily visible dominant markers are infrequent, this
method does not produce a high-resolution map, rather an approximation of the
mutation’s location. When paired with subsequent steps of complementation testing with
deficiencies in the area of the mutation, the actual physical location can be determined
(Sapiro et. al., 2013).
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Recombination can be an effective tool in genetics research in flies because there
is a complete absence of recombination in males. With recombination only occurring in
females, and balancer chromosomes, a necessary component to successfully perform
screens without crossing over, the transmission of chromosomes to progeny can be traced
unambiguously. Balancer chromosomes are inverted chromosomes that suppress meiotic
crossing over and prevent crossover products (Greenspan, 2004). Balancers complete this
task by producing recombinant chromatids that do not segregate normally in the first
meiotic division. These balancer chromosomes carry dominant marker alleles that allow
for visual identification of flies possessing the balancer, and most balancers contain
recessive lethal mutations that inhibit the balancer from appearing homozygous in a stock
(Greenspan, 2004). Specifically, on Drosophila’s second chromosome, commonly used
balancers include SM5 and CyO (Miller et. al., 2016).

1.3: Mutations of Interest
Proper nervous system development requires appropriate gene specification and
strict organization of many neural cells. One of these neural cell types is glia. Glia have
many roles in the developing nervous system: they balance neural stem cell proliferation,
control the differentiation of neural precursors, ensheath neurons, consume neural waste
produced during development, and advance synapse establishment and maturation (Stork
et. al., 2012). In order to achieve these roles, neural precursors must first differentiate into
glia. A master regulator of glial cell fate in Drosophila is the glial cells missing (gcm)
gene. The protein product of gcm is a DNA-binding transcription factor required for the
development of almost all glial cells in Drosophila. When gcm is expressed, neural cells
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have a glial fate, and when absent, neural cells take on a neuronal fate (Jones, 2008).
Homologs of gcm in mammals have been identified with conserved molecular properties.
In both Drosophila and the vertebrate nervous system, glial cell differentiation is closely
related to neurogenesis. With the preservation of similar genes between species,
comparable mechanisms of gliogenesis may be seen in Drosophila and vertebrates
(Jones, 2008).
In order to completely understand gliogenesis, mutations influencing the process
must be observed and characterized. Relevant mutations were discovered in a genetic
screen in Dr. Brad Jones’ lab using EMS (Jones, 2008). The main objective of this screen
was to discover genes affecting glial cell patterning, positioning, migration, function, and
other elements of differentiation. This was accomplished using antibody staining on the
glial-specific protein, Reversed Polarity (Repo). While Gcm is pertinent to differentiating
neural precursors to glial cells, its expression fades during the embryonic phase (Stork et.
al., 2012). For that reason, the steadily expressed Repo is stained. A transcriptional target
of Gcm, repo is a gene in Drosophila expressed in all glial cells excluding midline glia
which makes it an excellent marker for glial cells (Jones, 2008).
Drosophila embryos are well equipped for techniques that allow for concise in
vivo studies of glial-expressed genes in central nervous system (CNS) development.
Common techniques used for this purpose are immunohistochemistry, in situ
hybridization, and live imaging which all take advantage of tissue transparency in the
embryo (Stork et. al., 2012). Jones used these techniques to find each mutant—D19,
DD68, and FF12—while examining hundreds of lines from the mutagenesis screen
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(Jones, 2008). These mutants were stained with anti-Repo using immunohistochemistry
to visualize the glia during the embryonic stage (Figure 1).
Mutations of interest—those affecting repo expression and ultimately glia—were
analyzed for their effect on glial cell development and their relationship with gcm. As
shown in Figure 1, all three mutations are embryonic lethal as homozygotes and show
irregular patterns of glia in their CNS. Accordingly, these mutants are all candidates for
further characterization. In this study, I use recombination mapping to locate the position
of three target mutants on Drosophila’s second chromosome: D19, DD68, and FF12.
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Figure 1. Mutant embryos stained with Repo monoclonal antibody. The anti-Repo
stain of mutants D19, DD68, and FF12 makes the glial pattern abnormalities visible when
compared to the wild type (WT). Anterior is up. The embryos pictured are homozygous
for their mutations.
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CHAPTER 2
MATERIALS AND METHODS
2.1: Drosophila husbandry
The following mutated stocks were generated in a genetic screen using EMS:
D19, DD68, and FF12. Stocks containing dominant markers were collected from BDSC:
389, 1366, and 5194. Stock 389 contained dominant markers S[1] and wg[Sp-1]; stock
1366 contained dominant markers wg[Sp-1], Bl[1], and L[rm]; stock 5194 contained
dominant markers L[2] and Pin[1]. Table 1 displays these markers with necessary
mapping material. All flies were cultivated on cornmeal molasses media with yeast.
Genotype

Name

cM

Cytology

S[1]

Star, Asteroid

2-1.3

21E4

wg[Sp-1]

Sternopleural

2-22

27F1

Bl[1]

Bristle

2-54.8

38B5

L[rm] or L[2]

Lobe

2-72

51A4

Pin[1]

Pin

2-107.3

60C6-D1

Table 1. Valuable dominant markers expressing observable phenotypes on Drosophila’s
second chromosome for mutation mapping (adapted from Sapiro et. al., 2013).
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2.2: Scoring Markers
Crosses were performed at 25oC with three to six virgins and two to six males per
cross. Nine crosses were set up in order for each mutation to be crossed with dominant
markers that spanned the entire chromosome. Therefore, stocks D19, DD68, and FF12
were each crossed with stocks 389, 1366, and 5194. Initially, mutant virgins were crossed
with dominant marker males. The F1 progeny produced from these crosses were then
examined for the presence of the balancer chromosome, CyO (curly wings). Virgin
females lacking the balancer (i.e. females with straight wings) were collected for the
second cross with mutant males. The resulting F2 progeny were then scored for the
presence of dominant markers and the absence of the balancer (Figure 2). The phenotypes
of each dominant marker are: Star (S), scored for smaller, narrower eye with a rough and
rounded texture; Sternopleural (Sp), scored for extra bristles on the sternopleurite; Bristle
(Bl), scored for short, thick bristles in the thoracic region; Lobe (L), scored for reduced
eye size; and Pin (Pin), scored for short, thick bristles thoracic bristles. The F2 progeny
that are relevant to this mapping method are those that have either lost one or both
dominant markers in a pair (Figure 3). For instance, when the pair S,Sp is examined, the
only progeny necessary to determine the map location are S,+, +,Sp, and +,+ (Sapiro et.
al., 2013).
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Figure 2. Recombination Mapping Scheme. In the parental cross (P), mutant
Drosophila were crossed with a stock containing dominant markers on the second
chromosome. The resulting progeny were screened for females containing the dominant
markers and the chromosome carrying the mutation of interest (no balancer, CyO,
progeny). These females were backcrossed with males from the mutant stock for the F1
cross. The resulting progeny are scored for the absence of CyO and loss of L and/or Pin
(Adapted from Sapiro et. al., 2013).
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Figure 3. Possible Recombination Events. Potential recombination events between the
mutant and dominant marker chromosomes contingent upon the mutation being inside or
outside of the pair of markers. If recombination occurs in “a” or “d,” the recombinant
chromosome is viable with progeny containing both markers (L, Pin). If recombination
occurs in “b,” the recombinant chromosome containing only L is lethal and the
recombinant progeny with Pin are viable (+, Pin progeny). The opposite is true for “c,”
resulting in L, + progeny. The ratio of these recombination events indicates the
approximate position of the mutation. As in the first example, a recombination event
occurring in “e” or ‘h” results in viable L, Pin progeny. A recombination event in “f”
produces only +, Pin. L, + progeny are only possible if double recombination occurs at
“f” and “g” (adapted from Sapiro et. al., 2013).
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The viable recombinant progeny in the F2 generation that have lost one or both
markers are counted to obtain a ratio from them. If unmarked progeny are absent or
infrequent, then the mutation of interest is located within the two markers and the ratio of
the splits (S,+ and +,Sp) determines the approximate position of the mutation between the
markers (Figure 4). If unmarked progeny are frequent or common, then the mutation is
located outside of the markers. The ratio of the splits, in this case, would be used to
determine the direction of the mutation compared to the markers. So if S,+ is more
frequent than +,Sp, then the mutation is on the outside side of S (to the left) rather than Sp
(to the right), and vice-versa.

𝑙𝑜𝑠𝑠 𝑜𝑓 𝑙𝑒𝑓𝑡
𝑚𝑎𝑝
𝑐𝑀 𝑜𝑓 𝑙𝑒𝑓𝑡
𝑐𝑀 𝑏𝑒𝑡𝑤𝑒𝑒𝑛
𝑚𝑎𝑟𝑘𝑒𝑟
× !
-+!
- = 9𝑝𝑜𝑠𝑖𝑡𝑖𝑜𝑛 ;
𝑙𝑜𝑠𝑠 𝑜𝑓 𝑙𝑒𝑓𝑡
𝑙𝑜𝑠𝑠 𝑜𝑓 𝑟𝑖𝑔ℎ𝑡
𝑚𝑎𝑟𝑘𝑒𝑟𝑠
𝑚𝑎𝑟𝑘𝑒𝑟
!
-+!
𝑐𝑀
𝑚𝑎𝑟𝑘𝑒𝑟
𝑚𝑎𝑟𝑘𝑒𝑟
!

Figure 4. The Formula for Genetic Map Position. Once the mutation is determined to
be inside the markers, the number of F2 progeny that have lost one marker are counted
and used in this equation to find the approximate location (adapted from Sapiro et. al.,
2013).

The genetic map position obtained from recombination analysis then
corresponded with the physical position or chromosomal cytology. Since there is not a
linear relationship between genetic and physical positions, each mutation’s estimated
location was compared with known information about the position of local genes (Sapiro
et. al., 2013). This information was found using the cytogenetic map published in The
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Genome of Drosophila melanogaster as well as information made available on FlyBase
Gene Reports. (Lindsley and Zimm 1992, Marygold et al. 2013).

14

CHAPTER 3
RESULTS
Estimated chromosomal locations were determined for all three mutations:
FF12, DD68, and D19. My recombination mapping method tracked the lethal phenotype
of these mutations. After estimated genetic map locations were found, they were
converted into physical map locations using a cytogenic map and conversion table
available on FlyBase.
Mutation

cM

cyto

FF12

76.7

52E

DD68

87.7

56B

D19

72

51B

Table 2. Estimated chromosomal location of mutations.
As shown in Figure 5, each mutation’s location for all three lines was found when
crossed with stock 5194 within the interval of dominant markers L and Pin. This was
determined by the lack of flies without either dominant marker. For FF12, DD68, and
D19 there were no non-balancer F2 progeny missing both L and Pin. The crosses
between stocks 389 and 1366 and the mutant stocks mainly indicated that the mutation
was in the direction of L, Pin region by having more flies present with the dominant
marker on the right than on the left, with the exception wg[Sp-1], Bl[1]. In both DD68
and FF12, there were more wg[Sp-1] than Bl[1]. This is likely due to Bl (54.8 cM) being
located near the centromere (~55 cM) (Lindsley and Zimm, 1992). The centromere
15

causes inhibitory effects on recombination rates, and therefore makes recombination an
inefficient way to map adjacent mutations (Sapiro et. al., 2013).
The D19 x 389 cross did not produce any viable nonbalancer F1 progeny, so the
second cross was unable to be conducted and analyzed. While this cross with dominant
markers S and wg[Sp-1] was unable to be falsified, there is empirical evidence in support
of mutation D19 being located between L, Pin. As shown in Figure 5, the Bl, L[rm] split
suggests that the mutation is to the right of L[rm]. Also, the L, Pin split did not have any
nonbalancer F2 progeny that lacked both L and Pin—the key indicator of the mutation
being within the markers.

Figure 5A. The Process of locating mutation FF12. (Adapted from Sapiro et. al.,
2013).
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Figure 5B. The Process of locating mutation DD68. (adapted from Sapiro et. al., 2013).

Figure 5C. The Process of locating mutation D19. (adapted from Sapiro et. al., 2013).
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CHAPTER 4
DISCUSSION
The results obtained from recombination mapping are only approximations
(Sapiro et. al., 2013). In order to determine an exact location from this point, deletion
mapping must be used. In deletion mapping, fly stocks that have molecularly defined
deficiencies are crossed with the mutants (Kahsai and Cook, 2018). Wherever the mutant
fails to complement is the location causing the lethal phenotype. It is important to verify
embryonic phenotypes in mutant over deficiency embryos by staining for Repo. Since the
approximate location has now been discovered, only deficiencies spanning the region
around the estimated location are needed. The following deficiencies ranging 51B-53D
are needed to adequately test the region around FF12 (~52E): Df(2R)ED2419,
Df(2R)ED2436, Df(2R)ED2486, and Df(2R)ED2522. The following deficiencies ranging
55A-57A are needed to adequately test the region around DD68(~56B): Df(2R)ED3610,
Df(2R)ED3683, Df(2R)Exel6069, Df(2R)BSC135, Df(2R)ED3716, Df(2R)BSC782,
Df(2R)ED3728, and Df(2R)ED3737. Finally, the following deficiencies ranging 49E-52E
are needed to adequately test the region around D19(~51B): Df(2R)CX1,
Df(2R)BSC361, Df(2R)ED2354, Df(2R)ED2419, and Df(2R)ED2436. These
deficiencies can be obtained from BDSC. If the deficiencies complement the entire
region of D19’s location, the D19 x 389 cross should be performed again to falsify this
area as the possible mutation position. The accuracy of recombination mapping can be
improved by increasing the number of flies used in each cross. This would allow for a
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greater F2 generation to be produced and scored, directly increasing the accuracy of
position estimates. Mapping resolution could also be improved by increasing the density
of dominant markers with which the mutants are crossed.
Once an exact position of FF12, DD68, and D19 is found with complementation
testing, the mutations should then be associated with sequence-defined genes. We assume
theses mutations are homozygous lethal. If the results turn out to be inconclusive, then
this assumption should be tested. Some possible genes affecting nervous system
development that FF12 could be linked to based on its estimated location are spinster,
dystroglycan, and aspartyl b-hydroxylase. DD68’s estimated location also overlapped
with a gene that has a role within the nervous system: enabled, as found on FlyBase.
While these are just a few of many possible genes the mutations could affect, it confirms
the presence of neural-related genes within the regions around the mutations. Mutations
are typically studied when they are related to a gene, therefore completing the mapping
process will allow the mutations to be sought after more often and further researched.
This could possibly show that the mutation is an allele of a gene. Ultimately, the
mutations’ positions could provide a novel and more comprehensive perspective of a
gene and its function.
Mutants FF12, DD68, and D19 all exhibited pattern and expression errors when
stained for Repo. Thus, these mutants are suspected to affect genes necessary for
gliogenesis. The mutants could disturb gcm or a known target gene such as repo; on the
other hand, they could disturb a novel gene and lead to the discovery of new gcm target
genes. In order to determine the extent of the mutations’ effects, the next step would be to
stain the mutant lines with a series of antibodies (i.e. anti-Engrailed, anti-Even-skipped,
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etc.) against indicators in the CNS and peripheral nervous system to characterize a greater
depth of pattern formation, neural specification, and axon pathfinding. These antibody
staining procedures should reveal whether each mutant’s defect in gliogenesis is confined
to glial cells, or a more broad developmental process (Jones, 2008).
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